openPR Logo
Press release

Beta-Glucan Market growth, business opportunities, share value, key insights and size estimation by 2031 | AIT Ingredients, Ceapro Inc, Cargill Inc, Tate and Lyle Plc, Biorigin Zilor

09-11-2023 08:01 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Global Insight Services

Beta-glucan is a type of soluble fiber found in the cell walls of certain plants. It's been shown to have various health benefits, including lowering blood sugar and cholesterol levels, boosting immunity, and improving gut health.

Get Access to A Free Sample Copy of Our Latest Report - https://www.globalinsightservices.com/request-sample/GIS20592

Beta-glucan is thought to work by increasing the number of immune cells in the body and by helping these cells function more effectively. Additionally, beta-glucan may help slow down the absorption of sugar from the gut, which can help keep blood sugar levels under control.

Key Trends

The key trends in Beta-Glucan technology are the development of new and improved methods for the production of Beta-Glucan, the development of new and improved formulations of Beta-Glucan, and the development of new and improved applications for Beta-Glucan.

The development of new and improved methods for the production of Beta-Glucan has led to the development of new and improved formulations of Beta-Glucan.

The development of new and improved formulations of Beta-Glucan has led to the development of new and improved applications for Beta-Glucan.

Read Full Research Report - https://www.globalinsightservices.com/reports/beta-glucan-market/

The development of new and improved applications for Beta-Glucan has led to the development of new and improved methods for the production of Beta-Glucan.

Key Drivers

The key drivers of Beta-Glucan market are the increasing awareness of the health benefits of Beta-Glucan, the growing demand for healthy and natural food products, and the increasing trend of functional food and beverage consumption.

The increasing awareness of the health benefits of Beta-Glucan is the major driver of the market. The health benefits of Beta-Glucan are backed by scientific evidence and this is the major reason for the growing popularity of this ingredient.

The other drivers of the market are the growing demand for healthy and natural food products and the increasing trend of functional food and beverage consumption.

Restraints & Challenges

The key restraints and challenges in Beta-Glucan market are as follows:

Stringent regulations regarding the use of beta-glucan in food and beverages.
Limited availability of raw materials.

Request For Customization - https://www.globalinsightservices.com/request-customization/GIS20592

Market Segments

The beta-glucan market is segmented by source, category, application, and region. By source, the market is segmented into mushroom, yeast, seaweed, and grains and cereal. On the basis of category, it is bifurcated into soluble, and insoluble. Based on application, the market is classified into personal care, pharmaceutical, and others. Region-wise, the market is segmented into North America, Europe, Asia Pacific, and Rest of the World.

Key Players

The global beta-glucan market includes players such as Kerry Group Plc, Frutarom, Garuda International Inc, Super Beta Glucan, Kemin Industries, AIT Ingredients, Ceapro Inc, Cargill Inc, Tate and Lyle Plc, Biorigin Zilor, and others.

Buy Now - https://www.globalinsightservices.com/checkout/single_user/GIS20592

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology

New Report Published by Global Insight Services -https://www.globalinsightservices.com/reports/hydrogen-projects-database/?utm_source=utm_source%3Dopenpr_pranali_pawar&utm_medium=member_desktop

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Beta-Glucan Market growth, business opportunities, share value, key insights and size estimation by 2031 | AIT Ingredients, Ceapro Inc, Cargill Inc, Tate and Lyle Plc, Biorigin Zilor here

News-ID: 3202609 • Views:

More Releases from Global Insight Services

Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing at 17.5% CAGR | Overall Study Report
Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing …
The Immuno Oncology Drugs Market is rapidly emerging as a transformative segment in the global healthcare industry. These drugs harness the body's immune system to identify and attack cancer cells, offering innovative treatment alternatives to traditional chemotherapy and radiation therapies. Immuno-oncology therapies include monoclonal antibodies, checkpoint inhibitors, cancer vaccines, and cell-based therapies such as CAR-T cells. The growth of this market is primarily driven by advancements in biotechnology, an improved
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Overall Study Report
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Ove …
The GLP 1 Market is experiencing unprecedented growth, fueled by the rising prevalence of type 2 diabetes and obesity globally. GLP-1, or glucagon-like peptide-1 receptor agonists, represents a groundbreaking therapeutic class that improves insulin secretion, reduces glucagon production, and slows gastric emptying. These mechanisms not only enhance glycemic control but also support weight management, making GLP-1 therapies a preferred choice among healthcare providers and patients alike. Over the years, the
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAGR | Key Players: EasyMile, Navya, Aurrigo
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAG …
Market Overview Autonomous Bus Market is revolutionizing the future of urban mobility through advanced automation technologies. Valued at $2.1 billion in 2024, the market is projected to reach $11.6 billion by 2034, expanding at a strong CAGR of 18.8%. This market focuses on the development and deployment of self-driving buses equipped with cutting-edge sensors, artificial intelligence, and vehicle-to-everything (V2X) communication systems. These buses are designed to improve road safety, enhance passenger
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | Key Players: Apollo Tyres, Nokian Tyres, Hankook Tire
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | …
Market Overview Automotive Tire Market is experiencing remarkable growth as the industry embraces innovation, sustainability, and digital transformation. Valued at $406 billion in 2024, the market is projected to soar to $976.7 billion by 2034, reflecting a CAGR of 9.2%. This expansion is primarily driven by the surge in global vehicle production, growing consumer preference for durable and high-performance tires, and the increasing adoption of smart tire technologies. The Automotive Tire

All 5 Releases


More Releases for Beta

Beta-lactam and Beta-lactamase Inhibitors Market Emerging Trends and Growth Pros …
The global beta-lactam and beta-lactamase inhibitors market is valued at approximately $60 billion in 2024, driven by the rising prevalence of bacterial infections and the increasing resistance to traditional antibiotics. The market is projected to reach around $85 billion by 2034, reflecting a robust growth trajectory. This results in a Compound Annual Growth Rate (CAGR) of approximately 6.5% during the forecast period of 2025-2034. Exactitude Consultancy., Ltd. released a research report
Beta-Lactams & Beta-Lactamase Inhibitors: A Persistent Powerhouse in the Antibio …
The antibiotics market, despite facing challenges, remains a critical sector in global healthcare. Within this landscape, the Beta-Lactam and Beta-Lactamase Inhibitor segment stands out as a high-opportunity area, driven by the continued prevalence of bacterial infections and the ongoing fight against antimicrobial resistance (AMR). Market Dynamics and Growth Drivers Beta-lactam antibiotics, including penicillins and cephalosporins, have been the cornerstone of antibacterial therapy for decades. Their broad spectrum of activity and generally favorable
apuem - beta
Today the beta phase of apuem starts. Our goal is to create the largest web app collection, and for that we need your help. So if you know a useful online tool that you like to use, suggest it to us. See more: apuem.com/suggestions We appreciate any kind of participation. Thank you very much! Apuem Finkenhofstraße 27 60322 Frankfurt am Main Germany Jacob Kearson support@apuem.com More Information: apuem.com/contact We and our community search for the best web apps
Beta-lactam and Beta-lactamase Inhibitors Market to Reach $34,170 Million by 202 …
Global beta-lactam and beta-lactamase inhibitors market size was $27,126 million in 2018, and is projected to reach $34,170 million by 2028, growing at a CAGR of 2.3% from 2019 to 2028. The cephalosporin segment accounted more than two-fifths of the total beta-lactam and beta-lactamase inhibitors market share in 2018. Download Report Sample PDF @ https://www.alliedmarketresearch.com/request-sample/5427 Beta-lactam and beta-lactamase inhibitors are chemical compounds of natural or semi-synthetic or synthetic origin. They inhibit
Beta-lactam and Beta-lactamase Inhibitors Market Outlook from 2019 to 2028
"According to a new report published titled, ""India Heat Exchangers Market by Type, Material of Construction, and End-User Industry: Opportunity Analysis and Industry Forecast, 2019-2026,"" the India heat exchangers market accounted for revenue of $454.4 million in 2018, and is anticipated to generate $890.0 million by 2026. The market is projected to grow at a CAGR of 8.6% from 2019 to 2026. Heat exchangers are devices that transfer energy between fluids
Beta-lactam and Beta-lactamase Inhibitors Market Size, Share, Development by 202 …
Global Info Research offers a latest published report on Beta-lactam and Beta-lactamase Inhibitors Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Beta-lactam and Beta-lactamase Inhibitors players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Beta-lactam and Beta-lactamase